Barclays’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-36,510
| Closed | -$3.92M | – | 4561 |
|
|
2023
Q1 | $3.92M | Sell |
36,510
-10,222
| -22% | -$1.1M | ﹤0.01% | 1226 |
|
|
2022
Q4 | $5.14M | Sell |
46,732
-13,199
| -22% | -$1.45M | ﹤0.01% | 1095 |
|
|
2022
Q3 | $3.54M | Buy |
59,931
+58,463
| +3,982% | +$3.45M | ﹤0.01% | 1300 |
|
|
2022
Q2 | $41K | Sell |
1,468
-3,524
| -71% | -$98.4K | ﹤0.01% | 3808 |
|
|
2022
Q1 | $189K | Buy |
+4,992
| New | +$189K | ﹤0.01% | 3347 |
|